NO20041291D0 - Medisinske preparater som inneholder angiotensin II-reseptorantagonist - Google Patents

Medisinske preparater som inneholder angiotensin II-reseptorantagonist

Info

Publication number
NO20041291D0
NO20041291D0 NO20041291A NO20041291A NO20041291D0 NO 20041291 D0 NO20041291 D0 NO 20041291D0 NO 20041291 A NO20041291 A NO 20041291A NO 20041291 A NO20041291 A NO 20041291A NO 20041291 D0 NO20041291 D0 NO 20041291D0
Authority
NO
Norway
Prior art keywords
receptor antagonist
preparations containing
medical preparations
containing angiotensin
angiotensin
Prior art date
Application number
NO20041291A
Other languages
English (en)
Other versions
NO20041291L (no
Inventor
Toshio Sada
Toshimori Inaba
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20041291D0 publication Critical patent/NO20041291D0/no
Publication of NO20041291L publication Critical patent/NO20041291L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20041291A 2001-08-28 2004-03-26 Medisinske preparater som inneholder angiotensin II-reseptorantagonist NO20041291L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001257435 2001-08-28
PCT/JP2002/008629 WO2003020315A1 (fr) 2001-08-28 2002-08-27 Compositions medicinales contenant un antagoniste du recepteur d'angiotensine ii

Publications (2)

Publication Number Publication Date
NO20041291D0 true NO20041291D0 (no) 2004-03-26
NO20041291L NO20041291L (no) 2004-05-27

Family

ID=19085097

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041291A NO20041291L (no) 2001-08-28 2004-03-26 Medisinske preparater som inneholder angiotensin II-reseptorantagonist

Country Status (17)

Country Link
US (1) US20040198788A1 (no)
EP (1) EP1421953A4 (no)
KR (1) KR20040032969A (no)
CN (1) CN1589154A (no)
AU (1) AU2002328569B9 (no)
BR (1) BR0212254A (no)
CA (1) CA2459017A1 (no)
CO (1) CO5560583A2 (no)
HU (1) HUP0401696A2 (no)
IL (1) IL160438A0 (no)
MX (1) MXPA04001878A (no)
NO (1) NO20041291L (no)
NZ (1) NZ531346A (no)
PL (1) PL368843A1 (no)
RU (1) RU2004105965A (no)
WO (1) WO2003020315A1 (no)
ZA (1) ZA200401603B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3045174A1 (en) * 2003-01-31 2016-07-20 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension
US20090226420A1 (en) * 2005-11-10 2009-09-10 Elizabeth Hauser Methods of Determining the Risk of Developing Coronary Artery Disease
KR101345876B1 (ko) * 2012-01-31 2013-12-30 인제대학교 산학협력단 피마사르탄을 함유하는 세포, 조직 또는 장기 보존용 조성물
CN112979617A (zh) * 2019-12-17 2021-06-18 中国科学院苏州纳米技术与纳米仿生研究所 一种厄贝沙坦哌嗪盐及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8705837A1 (es) * 1985-01-10 1987-05-16 Tanabe Seiyaku Co Un procedimiento para la preparacion de derivados de naftaleno.
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
DE69016335T2 (de) * 1989-10-06 1995-06-01 Fujirebio Kk Pantothensäure Derivate.
ATE134624T1 (de) * 1990-02-19 1996-03-15 Ciba Geigy Ag Acylverbindungen
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
GB9025509D0 (en) * 1990-11-23 1991-01-09 Fujisawa Pharmaceutical Co New amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
ATE137744T1 (de) * 1990-11-26 1996-05-15 Taisho Pharmaceutical Co Ltd Anilidderivat
US5614519A (en) * 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
IS1756B (is) * 1991-02-21 2000-12-28 Sankyo Company Limited Hliðstæðuaðferð til framleiðslu 1-Biphenylmethylimidazole afleiða
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
JP3720395B2 (ja) * 1994-09-20 2005-11-24 京都薬品工業株式会社 新規ヘテロ環誘導体、その製造方法およびその医薬用途
ATE210116T1 (de) * 1995-10-05 2001-12-15 Kyoto Pharma Ind Neue heterozyklische derivate und ihre medizinische anwendung
FR2741619B1 (fr) * 1995-11-28 1998-02-13 Pf Medicament Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
CA2197364A1 (en) * 1996-02-15 1997-08-16 Toshikazu Suzuki Phenol compound and process for preparing the same
JPH11228416A (ja) * 1997-10-23 1999-08-24 Takeda Chem Ind Ltd 脂質低下剤
US6221897B1 (en) * 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19916108C1 (de) * 1999-04-09 2001-01-11 Aventis Pharma Gmbh Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
WO2002087580A1 (fr) * 2001-04-25 2002-11-07 Takeda Chemical Industries, Ltd. Promoteurs d'expression d'abc

Also Published As

Publication number Publication date
PL368843A1 (en) 2005-04-04
HUP0401696A2 (hu) 2004-11-29
ZA200401603B (en) 2004-10-19
BR0212254A (pt) 2004-10-19
AU2002328569B9 (en) 2005-10-27
US20040198788A1 (en) 2004-10-07
AU2002328569B2 (en) 2005-09-22
KR20040032969A (ko) 2004-04-17
CN1589154A (zh) 2005-03-02
IL160438A0 (en) 2004-07-25
CA2459017A1 (en) 2003-03-13
CO5560583A2 (es) 2005-09-30
NO20041291L (no) 2004-05-27
EP1421953A1 (en) 2004-05-26
MXPA04001878A (es) 2004-06-15
NZ531346A (en) 2005-10-28
EP1421953A4 (en) 2004-09-15
WO2003020315A1 (fr) 2003-03-13
RU2004105965A (ru) 2005-05-10

Similar Documents

Publication Publication Date Title
NO20033556D0 (no) Farmasöytiske preparater
NO20033384L (no) Farmasoytisk formulering
DE60208385D1 (de) Antineoplasische kombinationspräparate
NO20040084L (no) Peptid-baserte forbindelser
IS6994A (is) Arípíprazóllausn til gjafar um munn
NO20033785L (no) Farmasöytisk formulering
NO20025980D0 (no) Grensesnitt-detektor
NO20033205D0 (no) Terapeutiske kromanforbindelser
IS6582A (is) Mótunarpeptíð fyrir blóðkökkmyndunarviðtaka
DE50209245D1 (de) Neuroprotektives medikament
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
DE60219994D1 (de) Röntgensystem
ATA15392001A (de) Humanes endogenes retrovirus
NO20041291D0 (no) Medisinske preparater som inneholder angiotensin II-reseptorantagonist
DE10291905D2 (de) Pharmazeutische Zusammensetzung
AU2002328569A1 (en) Medicinal compositions containing angiotensin II receptor antagonist
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
DE10290431D2 (de) Bildgebendes medizinisches System
DE10107261B4 (de) Pharmazeutische Zusammensetzung
DE60134427D1 (de) Exzitatorische aminosäure-rezeptor-antagonisten
NO20041236L (no) Farmasoytisk formulering
FI20011760A0 (fi) Annostelusäkki
SE0103116D0 (sv) Pharmaceutical combination

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application